Influenza vaccination in the elderly
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Seasonal influenza is a prevalent and serious annual illness resulting in widespread morbidity and economic disruption throughout the population; the elderly and immunocompromised are particularly vulnerable to serious sequelae and mortality. The changing demographics worldwide to an aging society have important implications for public health policy and pharmaceutical innovations. For instance, primary prevention via immunization is effective in reducing the burden of influenza illness among the elderly. However, the elderly may be insufficiently protected by vaccination due to the immunosenescence which accompanies aging. In addition, vaccine hesitancy among the younger populations increases the likelihood of circulating infectious diseases, and thus concomitant exposure. While it is clear that the development of more immunogenic vaccines is an imperative and worthy endeavor, clinical trials continue to demonstrate that the current influenza vaccine formulation remains highly effective in reducing morbidity and mortality when well matched to circulating strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Broken Limits to Life Expectancy
Oeppen, J., & Vaupel, J. W. (2002) · Science · doi:10.1126/science.1069675 · Cited by 2,819
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064
Yager, E. J., Ahmed, M., Lanzer, K., Randall, T. D., Woodland, D. L., & Blackman, M. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071140 · Cited by 490 · cited 1×
“Both animal models and human studies have demonstrated reductions in antigen presentation by dendritic cells.(37,38,39,40,41,42,43)”
ResultComplications of Viral Influenza
Rothberg, M. B., Haessler, S. D., & Brown, R. B. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.040 · Cited by 456 · cited 1×
“The risk of influenza-related mortality increases sharply after 65 y of age.(8,9,10)”
BackgroundFalsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388 · cited 1×
“Boosting the vaccine dose 4-fold may confer a concomitant increase in antigenic presentation.(103,104,105,106) However, as noted previously, perhaps a better hallmark of immunogenicity and durability of protection in the elderly is the T lymphocyte response measured by ex vivo cytokine and granzyme B production, not a…”
BackgroundHolland, D., Booy, R., Looze, F. D., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M., Salem, H., Mills, G., Reid, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590434 · Cited by 254 · cited 1×
“The potential advantages of intradermal administration for vaccines are currently being investigated and side-by-side comparisons are promising.(99,100,101) A meta-analysis of 13 trials concluded that among the elderly, a higher intradermal dose conferred an immunogenic advantage when compared with intramuscular admin…”
BackgroundCochrane re-arranged: Support for policies to vaccinate elderly people against influenza
Beyer, W. E. P., McElhaney, J., Smith, D. J., Monto, A. S., Nguyen-Van-Tam, J. S., & Osterhaus, A. D. M. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.063 · Cited by 175 · cited 2×
“Specifically, the ESWI points out that the Cochrane Review failed to distinguish between seasons with high, mild or no circulation of an influenza virus, a factor which would dramatically influence any final effectiveness estimate.(84)”
BackgroundMcElhaney, J. E., Beran, J., Devaster, J.-M., Esen, M., Launay, O., Leroux-Roels, G., Ruiz-Palacios, G. M., van Essen, G. A., Caplanusi, A., Claeys, C., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70046-x · Cited by 164 · cited 2×
“An oil-in-water emulsion, such as MF59 or AS03, has also shown increased immunogenicity, cross-reactivity to other influenza strains, and a 25–50% reduction in hospitalization.(49)”
BackgroundKey role of T cell defects in age-related vulnerability to West Nile virus
Brien, J. D., Uhrlaub, J. L., Hirsch, A., Wiley, C. A., & Nikolich-Žugich, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090222 · Cited by 158
Cited by
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
Grolli, R. E., Mingoti, M. E. D., Bertollo, A. G., Luzardo, A. R., Quevedo, J., Réus, G. Z., & Ignácio, Z. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02249-x · Cited by 258
Metadata
- Authors
- Smetana, J., Chlibek, R., Shaw, J., Splino, M., & Prymula, R.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2017-08-04
- Volume
- 14
- Issue
- 3
- Pages
- 540-549
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W2736171204
- Cited by
- 168
- References
- 11
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influenza vaccination in the elderly. https://app.cochat.ai/papers/10.1080/21645515.2017.1343226
- The paper
- Smetana, J., Chlibek, R., Shaw, J., Splino, M., & Prymula, R. (2018). Influenza vaccination in the elderly. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2017.1343226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.